Skip to main content
OpenTrials
Completed

NCT Number: NCT06870682

Potential Effects of Novel Sensorimotor Upper Limb Rehabilitation Paradigm

Sensorimotor function of the upper limb is often impaired after stroke, even in the chronic phase (minimum 6 months after stroke). Currently, an optimal intervention combining both motor and sensory function, with focus on sensory processing (one of the most important sensory functions), does not exists. However, the research team has developed a novel therapy paradigm combining robot-based training, a transfer package to daily life activities, and a home program. As a first step, the investigators will examine the feasibility and potential benefits of this novel therapy approach within this pilot study by recruiting 10 persons with chronic stroke. The investigators hypothesize that this therapy approach is feasible and potentially effective in chronic stroke.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

KU Leuven

Leuven, 3001, Belgium

About this study

Sensorimotor function of the upper limb is often impaired after stroke, even in the chronic phase (minimum 6 months after stroke). Currently, an optimal therapy combining both motor and sensory function, with focus on sensory processing (one of the most important sensory functions), does not exists. However, the research team has developed a novel therapy paradigm combining robot-based training, a transfer package to daily life activities, and a home program. As a first step, the investigators will examine the feasibility and potential benefits of this novel therapy approach within this pilot study. This intervention study will recruit 10 persons with chronic stroke. The participants will be measured a first time with both robot-based and clinical assessments. Thereafter, the participant follows a 4-week control period, only receiving standard care. After the control period, a second measuring moment is planned using the same outcome measures as during the first measurement. Then, a the 4-week intervention is planned, whereby participants get 48 hours additional sensorimotor upper limb training. The participants will come 3 times per week to Leuven for a therapy session of two hours. During these therapy sessions, the participants receive one hour robot-based therapy and one hour transfer package training with a therapist. Additionally, the participants follow 6 times a week a 1-hour home program. After this intervention period, the particpants are measured a last time using the same outcome measures as during the previous measuring moments. The investigators hypothesize that this therapy approach is feasible and potentially effective in chronic stroke.

Optionally, if the participants is willing and able to, additional MRI and/or fNIRS assessments will be added to give a first idea regarding changes in brain structure, function and activity because of this novel therapy approach. This study will inform the investigators to finalize the protocol for a following RCT.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Written informed consent must be obtained prior to any screening procedures
  • A first-ever unilateral, supra-tentorial stroke, as defined by WHO (rapidly developing clinical signs of focal (or global) disturbance of cerebral function, with symptoms lasting 24 hours or longer or leading to death, with no apparent cause other than vascular origin)
  • ≥18 years old
  • Being in the chronic phase after stroke, i.e. > 6 months post stroke
  • Motor impairment in the upper limb, defined as Fugl-Meyer score >22 out of 66 to demonstrate moderate to full upper limb motor function (patients scoring <23 out of 66 will not be able to comply with the KINARM protocol)
  • Residual sensory upper limb impairment, defined as Tactile Discrimination Test score <24 out of 25
  • Impaired functionality, defined as Action Research Arm Test score <52 out of 57
  • Manageable spasticity for KINARM tasks

Exclusion criteria

  • Having musculoskeletal and/or other neurological disorders impacting care or prognosis
  • Having severe communication or cognitive deficits that interfere with the protocol
  • Any disorder, which in the investigator's opinion might jeopardise participant's safety or compliance with the CIP
  • Contraindications for robot-based therapy (e.g., uncontrolled epilepsy)
  • Participation in another clinical investigation
  • Having uncontrolled head movements (e.g. tremor), only relevant if participant is willing to receive the additional fNIRS assessments
  • Having any contra-indications for MRI, only relevant if participant is willing to receive the additional MRI assessments:
  • Pacemaker
  • Implantable Cardioverter Defibrillator (ICD)
  • Cochlear implant
  • Internal Insulin-pump
  • Deep brain stimulation
  • Any other metal device in body
  • Claustrophobia
  • Having a history of a neuropsychiatric or neurologic disorder before the diagnosis of stroke (e.g., depression, traumatic brain injury)
  • Use of psychoactive medication before the diagnosis of stroke (e.g., anti-depressive medication)
  • Use (or history of use) of drugs/alcohol
  • Being pregnant

Treatment and study plan

ROBUST

Behavioral

During a 4-week intervention, participants get 48 hours additional sensorimotor upper limb training. They will come 3 times per week to Leuven for a therapy session of two hours. During these therapy sessions, they receive one hour robot-based therapy and one hour transfer package training with a therapist. Additionally, they follow 6 times a week a 1-hour home program. This intervention can be distinguished from others since it integrates both motor and sensory function, with focus on sensory processing. It combines robot-based therapy, a transfer package to daily activities, and a home program.

Primary outcomes

  1. Action Research Arm Test

    Time frame: From first measuring moment to last measuring moment after 8 weeks.

    Clinical assessment of motor activity performance on an ordinal scale ranging from 0 to 57, with higher scores meaning better performance

Secondary outcomes

  1. Sensorimotor Action Research Arm Test

    Time frame: From first measuring moment to last measuring moment after 8 weeks.

    Clinical assessment of sensorimotor activity performance on an ordinal scale ranging from 0 to 57, with higher scores meaning better performance

  2. Fugl-Meyer upper extremity assessment

    Time frame: From first measuring moment to last measuring moment after 8 weeks.

    Clinical assessment of motor function on an ordinal scale ranging from 0 to 66, with higher scores meaning better performance

  3. Tactile discrimination test

    Time frame: From first measuring moment to last measuring moment after 8 weeks.

    Clinical assessment of sensory processing with an area under the curve based scoring system, with higher scores meaning better performance

  4. Stroke Impact Scale

    Time frame: From first measuring moment to last measuring moment after 8 weeks.

    A self-report questionnaire that evaluates disability and health-related quality of life after stroke. A higher score indicates less disability and better quality of life.

  5. Kinarm: Visually guided reaching task

    Time frame: From first measuring moment to last measuring moment after 8 weeks.

    Assessment of motor function using a 4-target centre-out reaching task on the Kinarm End-Point Lab

  6. Kinarm: Arm position matching task

    Time frame: From first measuring moment to last measuring moment after 8 weeks.

    Assessment of limb position sense using a 9-target mirror-matching task on the Kinarm End-Point Lab

  7. Kinarm: Passive and active discrimination task

    Time frame: From first measuring moment to last measuring moment after 8 weeks.

    Task on the Kinarm End-Point Lab used to assess passive and active sensory processing

  8. Optionally: MRI assessment

    Time frame: From first measuring moment to last measuring moment after 8 weeks.

    MRI scan to study the structure and function of the brain.

  9. Optionally: fNIRS assessment

    Time frame: From first measuring moment to last measuring moment after 8 weeks.

    The patient will be fitted with the fNIRS head cap during a standardized task on the Kinarm robot. This fNIRS measure studies brain activity during a sensorimotor activity.

Sponsors and collaborators

Lead sponsor

KU Leuven

Other

Registry information

Official study title

Potential Effects of a Robot-based Upper Limb Rehabilitation Paradigm in Different Subgroups After Stroke: a Pilot Study

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Mar 11, 2025
Registry last updated
Mar 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.